Aptuit has acquired the Medicines Research Centre, Verona, Italy, formerly a GSK
R&D site, in a uniquely structured partnership arrangement.
This site will expand and strengthen Aptuit’s integrated scientific and service
offering to the benefit of all Aptuit clients.
"This is a very exciting time for Aptuit and its clients. We now offer more services,
capacity and even more scientific excellence", commented Tim Tyson, CEO, Aptuit
Inc.
Read the Press Release
